Publications

Browse Publications

Sort by: Title  Date

  • Alliance in the News, Science in the Spotlight
    Alzheimer’s Biomarkers are Ready for Research
    In a March 1st interview, Dr. John Morris, co-chair of the Alzheimer's Disease Biomarker Expert Working Group (convened by the Alliance for Aging Research), explains what biomarkers are and how they will help research in the field of Alzheimer's disease and related dementia.

    John C. Morris is the Harvey A. and Dorismae Hacker Friedman Distinguished Professor of Neurology, Professor of Pathology and Immunology, Professor of Physical Therapy, and Professor of Occupational Therapy at Washington University. He also is the Director and Principal Investigator of the Alzheimer's Disease Research Center.

    For More info on the promise of biomarkers in Alzheimer's, click here.
  • Feature Article
    Treatments for Age-Related Macular Degeneration: Going Head to Head
    Spring 2011 | Alliance for Aging Research
    Related topics: Access to Breakthroughs    Drug Development  Drug Safety  Health  Medical Innovation  Policy  Quality of Care  Research  Vision Loss  

    Exciting treatments make slowing and even restoring vision loss in wet age-related macular degeneration (wAMD) patients a reality. Two of the most frequently used treatments are currently in the spotlight as they go head-to-head in clinical trials comparing their effectiveness, and to some extent, exploring their costs.
  • Feature Article
    Pain and Confusion: Figuring Out How to Safely Treat Pain
    Spring 2010 | Alliance for Aging Research
    Related topics: Drug Safety  Health  Persistent Pain  

    Are you or a loved one dealing with persistent pain but confused about what medications are safe? Understandably so! Treating persistent pain can be challenging and now warnings about the risks of leading pain relievers have left many of us wondering what we can do to safely treat our pain.
  • Report
    Pain Management Survey
    September 2009
    Related topics: Drug Safety  Persistent Pain  Policy  

    The Alliance for Aging Research commissioned a nationwide survey of 800 U.S. adults age 65 and older to better understand their attitudes, perceptions and concerns regarding age-related pain management and changes under consideration by the FDA to over-the-counter acetaminophen products. Clarus Research Group conducted the survey on behalf of the Alliance for Aging Research between September 14 and September 18, 2009. Support for the survey was provided by McNeil Consumer Healthcare, Division of McNeil-PPC, Inc.
  • Get Mad Column
    The Savings and Safety of Drug Importation
    Spring 2009
    Related topics: Drug Development  Drug Safety  Policy  

    The president and Congress are embarking on a fervent campaign to reform our damaged health care system. Few would disagree that there is waste in our current system, and even fewer would disagree with the fact that we need to bring healthcare to the 46 million Americans who are currently uninsured. But, many in Washington and across the country disagree on how to go about financing the massive health care overhaul that lawmakers are now proposing.
  • Alliance Views
    Manage Your Over-the-Counter Medications
    Summer 2007
    Related topics: Drug Safety  

    Over-the-counter medications can be an effective and relatively inexpensive way to reduce pain, get a good night’s sleep, and be more productive. But because they’re available easily without a prescription, many people may mistakenly believe that taking them contains no risk.
  • Report
    When Medicine Hurts Instead of Helps:
    Preventing Medication Problems in Older Persons

    June 1998 | Alliance for Aging Research
    Related topics: Drug Safety  

    Misuse of everyday medications by older Americans costs the United States billions of dollars, and thousands of lives, every year, Older people are more vulnerable to adverse drug reactions due to the numbers of medications they take and the biological changes that accompany aging and disease.

    When Medicine Hurts Instead of Helps focuses on this susceptibility of older Americans. An estimated 106,000 fatal adverse drug reactions occur ever year and the cost of medication-related problems in all age groups approaches $85 billion annually. Recommendations to alleviate this tragic and preventable problem are outlined.

View all Publications »